Bayer: Mixed overall picture in Q1

NEUTRAL, Fair Value EUR110 (0%)
News published on April Wednesday 27, 2016
Share on

The conference call yesterday afternoon confirmed a mixed first read-out from the first-quarter performance as reflected in the press release. There were some positive one-offs during Q1 and the remainder of the year is expected to show some tougher conditions in pharmaceuticals and in crop sciences. Updates on the pipeline also revealed several setbacks that add to questions about mid-term growth prospects. In all, we are left with a very mixed feeling and NEUTRAL therefore looks like the best rating to have on the stock.

For more information, please contact

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities